$8.47 -0.12 (-1.40%)
12/3/2009 4:01 PM

Boston Scientific Corp. (BSX)

CAPS Rating: 3 out of 5

The Company develops, manufactures & markets medical devices that are used in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology & neuromodulation.

Recs

18
Member Avatar theinsider2 (< 20) Submitted: 10/29/2008 11:22:27 AM : Underperform Start Price: $7.85 BSX Score: +12.79

Considering he sold off $150 million of his stock in Boston Scientific a week and a half prior to reporting their 3rd quarter results, which comes out today. I would have hated to see him hold on to that to show confidence in the company....I mean, it's hard enough to make it by on $150 million anymore. NO CONFIDENCE...

Report this Post 1 Comment
Member Avatar tantrum1 (< 20) Submitted: 12/30/2008 11:33:19 AM
Recs: 0 Rec This

Stent and Defib sales will continue huge businessNew renal stent just FDA approved innovator will come back strong................ Stent sales will continue huge business

Report this Post

Featured Broker Partners